Bionano genomics users present the saphyr system as a novel diagnostic tool for hematological malignancies at ash 2020

San diego, dec. 03, 2020 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) announced that its saphyr system for optical genome mapping is being introduced as a novel diagnostic tool for heme malignancies by dr. rashmi kanagal-shamanna of the md anderson cancer center at the annual meeting of the american society of hematology (ash). with more than 18,000 members from nearly 100 countries, the ash is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases. the annual meeting is being held virtually at hematology.org from december 5-8.
BNGO Ratings Summary
BNGO Quant Ranking